Although HCV screening is feasible in people living with HIV, the gap between universal access and universal successful treatment is still not defined.We studied the rate of access and response to Direct Acting Antivirals (DAA) in a cohort of HIV/HCV seen for care in Italy.

Predictors of access and response to DAA in a cohort of human immunodeficincy virus/hepatitis C virus co-infected patients in Italy.

G Nunnari;G. F. Pellicanò.
2017-01-01

Abstract

Although HCV screening is feasible in people living with HIV, the gap between universal access and universal successful treatment is still not defined.We studied the rate of access and response to Direct Acting Antivirals (DAA) in a cohort of HIV/HCV seen for care in Italy.
2017
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3141771
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact